Senior Specialist, Procure to Pay, Europe
Revolution Medicines - Basel, Basel-Stadt, Switzerland
Posted Jun 4, 2026
Benefits
- Parental leave
- Not verified
- Non-birth-parent leave
- Not verified
- Family-building benefits
-
- Fertility benefits: Not verified
- Adoption assistance: Not verified
- Surrogacy assistance: Not verified
- Mental health support
- Not verified
- Relocation assistance
- Not verified
- Childcare support
- Not verified
- Learning budget
- Not verified
- Verification
- Not verified checked Jun 7, 2026
- Salary
- Not verified
- 401(k) match
- Reported from DOL Form 5500 industry filing (not employer-specific)
Was this benefit information wrong? Tell us.
Market context
- U.S. role benchmark (BLS OEWS)
- $106,409 U.S. median for this role
- Projected growth (BLS Employment Projections)
- +7.7% - Faster than average
Matched to SOC 13-2011 - Finance aggregate by role bucket.
Source: U.S. Bureau of Labor Statistics, OEWS, May 2024 and Employment Projections, 2024-2034.
Role
Schedule
- Shift type
- Not verified
- Weekend work
- Not verified
Company
- Equity
- Offered Verified - SEC 10-K source checked Jun 20, 2026
Application
- Cover letter
- Not verified
- Assessment
- Not verified
- Deadline
- Not stated
Where they hire
State eligibility is not yet verified.
About this role
Senior Specialist, Procure to Pay, Europe Basel, Basel-Stadt, Switzerland Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Revolution Medicines Switzerland is seeking a motivated individual with a background in the life sciences industry to play a critical role in the accounting team. Reporting to the Senior Manager, Accounts Payable Europe, this newly created role will support the daily procure to pay operations across multiple European entities while ensuring accurate processing, adherence to internal controls and compliance with US GAAP and local statutory requirements. This role ensures accurate, timely, and compliant processing of purchase orders, vendor invoices, vendor payments, employee expense reimbursements and VAT filings while driving process improvements, standardization, and strong internal controls across the region. The role is located in Basel, Switzerland. - Ensure timely and accurate processing for vendor onboarding, vendor purchase orders, invoices, employee expense reports, and payments - Review invoice coding for correct legal entity, department, account, location and tax treatment. - Coordinate or support payment
Read the full description at www.revmed.com. FewerJobs shows a preview and links to the original posting.
Apply link not verified; last-live date unavailable.
What verified means
Verified means a displayed claim has field-level provenance to a source FewerJobs pulled: a government or employer source, or the original job posting. Posting-sourced facts are employer-stated and are labeled separately from government records.
Related jobs
-
Director, Regulatory Affairs, Europe (contractor)
Cytokinetics INC - Zug, Switzerland
-
Pension Broker
Aon plc - Zurich, Switzerland
-
Strategic Account Executive (Switzerland)
Datadog - Switzerland, Remote
-
Sr Program Director
Honeywell - Switzerland